DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,042 filers reported holding DANAHER CORPORATION in Q1 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $516,342,216 | -3.0% | 2,081,186 | -6.1% | 0.15% | +3.4% |
Q2 2023 | $532,178,437 | -12.5% | 2,217,410 | -8.1% | 0.15% | -16.6% |
Q1 2023 | $608,341,011 | -6.9% | 2,413,668 | -2.0% | 0.18% | -10.7% |
Q4 2022 | $653,591,340 | -1.8% | 2,462,480 | -4.4% | 0.20% | -9.7% |
Q3 2022 | $665,436,000 | -1.9% | 2,576,310 | -3.7% | 0.22% | +3.3% |
Q2 2022 | $678,147,000 | -23.2% | 2,674,927 | -11.1% | 0.21% | -7.1% |
Q1 2022 | $882,901,000 | -7.3% | 3,009,920 | +4.0% | 0.23% | -5.0% |
Q4 2021 | $952,114,000 | -7.2% | 2,893,877 | -14.2% | 0.24% | +5.3% |
Q3 2021 | $1,026,477,000 | +13.7% | 3,371,687 | +0.3% | 0.23% | +14.1% |
Q2 2021 | $902,435,000 | +8.7% | 3,362,779 | -8.8% | 0.20% | +5.9% |
Q1 2021 | $830,291,000 | -3.1% | 3,688,873 | -4.4% | 0.19% | -9.2% |
Q4 2020 | $856,779,000 | +10.6% | 3,856,931 | +7.2% | 0.21% | -3.7% |
Q3 2020 | $774,671,000 | +19.5% | 3,597,604 | -1.9% | 0.21% | +13.2% |
Q2 2020 | $648,220,000 | +30.9% | 3,665,784 | +2.5% | 0.19% | +10.5% |
Q1 2020 | $495,185,000 | -15.0% | 3,577,669 | -5.7% | 0.17% | +8.9% |
Q4 2019 | $582,396,000 | +4.4% | 3,795,210 | -1.7% | 0.16% | -0.6% |
Q3 2019 | $557,781,000 | -2.0% | 3,861,940 | -3.0% | 0.16% | -3.1% |
Q2 2019 | $569,089,000 | +23.2% | 3,981,875 | +13.8% | 0.16% | +18.1% |
Q1 2019 | $462,031,000 | +29.8% | 3,499,708 | +1.4% | 0.14% | +16.9% |
Q4 2018 | $355,995,000 | -1.3% | 3,452,549 | +4.0% | 0.12% | +15.7% |
Q3 2018 | $360,842,000 | +7.4% | 3,320,837 | -2.5% | 0.10% | +2.0% |
Q2 2018 | $336,104,000 | +21.1% | 3,405,995 | +20.1% | 0.10% | +22.0% |
Q1 2018 | $277,559,000 | +4.2% | 2,834,837 | -2.2% | 0.08% | +6.5% |
Q4 2017 | $266,333,000 | +17.4% | 2,899,346 | +8.4% | 0.08% | +10.0% |
Q3 2017 | $226,951,000 | -35.3% | 2,675,539 | -35.7% | 0.07% | -38.1% |
Q2 2017 | $351,027,000 | +7.5% | 4,159,584 | +8.6% | 0.11% | +6.6% |
Q1 2017 | $326,475,000 | +5.5% | 3,828,513 | -4.2% | 0.11% | -2.8% |
Q4 2016 | $309,347,000 | +14.2% | 3,994,305 | +15.6% | 0.11% | +9.0% |
Q3 2016 | $270,877,000 | -21.3% | 3,455,588 | +1.4% | 0.10% | -24.8% |
Q2 2016 | $344,208,000 | +1.5% | 3,408,001 | -4.7% | 0.13% | -1.5% |
Q1 2016 | $339,148,000 | -6.4% | 3,575,248 | -11.1% | 0.14% | -5.6% |
Q4 2015 | $362,219,000 | +1.5% | 4,021,489 | -6.4% | 0.14% | -4.0% |
Q3 2015 | $356,781,000 | -10.2% | 4,295,939 | -35.6% | 0.15% | -2.6% |
Q2 2015 | $397,399,000 | -46.1% | 6,670,894 | -29.3% | 0.15% | +6.2% |
Q1 2015 | $737,784,000 | +45.1% | 9,441,450 | +7.3% | 0.14% | -27.6% |
Q4 2014 | $508,388,000 | +5.7% | 8,795,499 | +1.9% | 0.20% | -1.5% |
Q3 2014 | $480,798,000 | +9.0% | 8,628,639 | +54.0% | 0.20% | +11.0% |
Q2 2014 | $441,270,000 | +0.7% | 5,604,818 | -4.1% | 0.18% | -2.2% |
Q1 2014 | $438,399,000 | -2.1% | 5,845,366 | +0.7% | 0.19% | -4.1% |
Q4 2013 | $448,026,000 | +10.7% | 5,804,130 | -0.6% | 0.19% | +1.0% |
Q3 2013 | $404,642,000 | +6.3% | 5,837,838 | -2.9% | 0.19% | -2.5% |
Q2 2013 | $380,542,000 | – | 6,012,288 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |